Inactivation of PL has been proven to have anti-obesity effects by forming a covalent bond with gastric and pancreatic lipase in the gut and stopping lipases turning dietary fat into absorbable monoglycerides and free fatty acids. The gene discussed is PNLIP; the disease is obesity due to melanocortin 4 receptor deficiency.